Home » Topics » BioWorld Science

BioWorld Science
RSS

Cytokine-inducing profile of imiquimod and two analogues characterized in monkeys

Feb. 19, 1998

Development of PNU-95666E moves ahead

Feb. 19, 1998

Hoechst prepares xanthines for cerebrovascular disorders

Feb. 19, 1998

Lilly claims thrombin inhibitors

Feb. 19, 1998

New natural or semisynthetic cytotoxic alkaloids from Indena

Feb. 19, 1998

New cell adhesion inhibitors from Shionogi

Feb. 19, 1998

Novel imidazoles from Shionogi target lymph nodes

Feb. 19, 1998

New gastrointestinal agents reported by Yoshitomi

Feb. 19, 1998

Shionogi investigates new cephem compounds

Feb. 19, 1998

Neurobiological Technologies: Q2 1998 highlights

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...